Crossmark

Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection

Crossref DOI link: https://doi.org/10.1186/s12885-022-09743-6

Published Online: 2022-06-17

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Nu

Wan, Xiaoting

Zhang, Hong

Zhang, Zitian

Guo, Yan

Hong, Duo
License Information

Text and Data Mining valid from 2022-06-17

Version of Record valid from 2022-06-17
More Information

Article History

Received: 3 January 2022

Accepted: 2 June 2022

First Online: 17 June 2022

Declarations

:

: This retrospective clinical study was approved by the Ethics Committee of the First Hospital of China Medical University, and was carried out in accordance with the Declaration of Helsinki. The requirement for the informed consent was waived.

: Not applicable.

: Y Guo is a current employee of GE Healthcare. The other authors have no competing interests to declare.

Document is current

Any future updates will be listed below